ACMUI Subcommittees

The Advisory Committee on the Medical Uses of Isotopes (ACMUI) advises the U.S. Nuclear Regulatory Commission (NRC) on policy and technical issues that arise in the regulation of the medical uses of radioactive material in diagnosis and therapy. The ACMUI's recommendations and comments to the NRC come through formal reports submitted by Subcommittees. Below is a list of Subcommittees, including their charges, members, established dates, deactivated dates, and any final, draft or interim reports. Subcommittee reports may also be found on the Subcommittee Reports Web Page.

On this page:

Active ACMUI Subcommittees
Past Subcommittee

Active ACMUI Subcommittees

Subcommittee Name	Subcommittee Charge	Subcommittee Members	Status
Giving Advice on ADVANCE Act of July 2024 Mission Statement	The subcommittee will provide recommendations and advice to support the Nuclear Regulatory Commission's (NRC) implementation of the ADVANCE Act.	Dr. Richard Harvey, Chair Dr. Michael Folkert Ms. Megan Shober Mr. Josh Mailman Dr. Hossein Jadvar Staff Resource: Katie Tapp	Subcommittee established 04/07/25
Potential AI Deep Learning Applications for NRC Medical Enterprise	The Subcommittee is tasked with exploring and evaluating the potential applications of artificial intelligence (AI) and deep learning technologies to enhance the efficiency and effectiveness of the Nuclear Regulatory Commission's (NRC) medical staff and ACMUI.	Dr. Andrew Einstein, Chair Dr. Joanna Fair Dr. Michael Folkert Mr. Josh Mailman Dr. Hossein Jadvar Consultant: Dr. John F. Angle Staff Resource: Maryann Ayoade	Subcommittee established 04/07/25
ACMUI Generic Reporting Process	The subcommittee is charged with establishing best practices for the preparation of reports, including guidance on writing subcommittee reports and developing effective presentations, including Commission presentations.	Ms. Megan Shober, Chair Dr. Harvey Wolkov Mr. Josh Mailman Mr. Richard Green Dr. Zoubir Ouhib Staff Resource: Lillian Armstead	Subcommittee established 04/07/25
Yttrium-90 (Y-90) Microsphere Gastrointestinal (GI) Deposition Medical Events Subcommittee	To evaluate changes in Y-90 microsphere brachytherapy practice and recent Y-90 microsphere medical events to identify potential cause of sudden increase in reported events involving unexpected GI deposition.	Dr. Richard Harvey, Chair Dr. Joanna Fair Mr. Zoubir Ouhib Dr. Michael O’Hara Dr. Michael Folkert Consultant: Dr. Fritz Angle Staff Resource: Ms. Sarah Spence	Subcommittee established 12/17/24 Final Report Submitted 4/7/25
Generic Process Checklist	To consider development of process checklists to minimize medical events.	Mr. Richard Green, Chair Ms. Melissa Martin Dr. Hossein Jadvar Ms. Rebecca Allen Mr. Zoubir Ouhib Dr. Richard Harvey Staff Resource: Mr. Daniel DiMarco	Subcommittee established 12/12/24 Final Report Submitted 4/7/25
Membership of an Interventional Radiologist	To assess ACMUI membership to determine if the ACMUI would like to propose to the Commission a change in membership to include an interventional radiologist	Dr. Andrew Einstein, Chair Dr. Hossein Jadvar Dr. Michael Folkert Ms. Rebecca Allen Dr. Richard Harvey NRC staff resource: Dr. Katie Tapp	Subcommittee established 4/8/24
Emerging Medical Technologies/Rubidium-82 Generator Rulemaking Subcommittee	To review and comment on the staff’s regulatory basis for the Emerging Medical Technologies/Rubidium-82 Generator rulemaking.	Ms. Megan Shober, Chair Dr. Ronald Ennis Dr. Harvey Wolkov Dr. Richard Harvey Dr. Hossein Jadvar Non-voting subcommittee consultant: Dr. John F. Angle NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 08/18/22 Final Report Submitted 12/19/22
Subcommittee on Radionuclide Generator Knowledge and Practice Requirements	To review and evaluate the knowledge and practice requirements for eluting, measuring and testing, and processing the eluate from radionuclide generator systems based on the evolution of radionuclide generator distribution. To evaluate and determine the appropriateness of the requirements and how best to obtain the required knowledge and practice. To evaluate whether and how additional knowledge and practice should be obtained as necessary to supervise the use of any radionuclide generator system.	Dr. Vasken Dilsizian Mr. Richard Green (Chair) Ms. Melissa Martin Ms. Megan Shober Dr. Harvey Wolkov NRC staff resource: Ms. Maryann Ayoade	Subcommittee established May 2021 Final Report Submitted 10/14/2021 Draft Report Submitted 9/8/21
Subcommittee on Extravasation	To provide advice on including medical event reporting criteria for extravasations. Original Charge 4/3/19: Review the U.S. Nuclear Regulatory Commission (NRC) staff’s Memorandum “Preliminary Evaluation of Radiopharmaceutical Extravasation and Medical Event Reporting” dated April 1, 2021 and provide feedback and recommendations. Charge expanded 3/7/24: Review and provide feedback and recommendations on the NRCstaff’s draft proposed rule, associated draft implementation guidance, and draft model procedures for reporting nuclear medicine injection extravasations as medical events.	Dr. Andrew Einstein Mr. Richard Green Dr. Richard Harvey Ms. Melissa Martin, Chair Ms. Megan Shober NRC staff resource: Mr. Daniel DiMarco	Subcommittee established on 04/03/19 Final Report Submitted 06/18/2024 Final Report Submitted 09/16/2021
Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material".	Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material". To review the revisions to Regulatory Guide 8.39, “Release of Patients Administered Radioactive Material” Charge expanded 10/4/2021 Review the CivaDerm technology and comment on the NRC staff’s draft CivaDerm additional licensing considerations memo. (completed 1/21/22) Note: Regulatory Guide 8.39 is being revised in two phases. Phase 1 updates the patient release guidance, including information for patient instructions and updates to Table 3. Phase 2 will include updates to the dosimetric equations, methodologies, and tables used to calculate dose to members of the public from released patients. Phase 1 was completed on 6/19/19.	Dr. Hossein Jadvar Dr. Johanna Fair Ms. Melissa Martin Ms. Megan Shober, Chair Mr. Josh Mailman NRC staff resource: Dr. Katie Tapp	Subcommittee established 09/21/18 CivaDerm Final Report submitted 01/21/22 Phase 2 Final Report Submitted 01/21/22 Phase 1 Final Report Submitted 06/19/19
Training and Experience Requirements for All Modalities Subcommittee (2024)	To review and evaluate the training and experience requirements for all modalities in 10 CFR Part 35. *Charge Expanded 8/6/24: To provide recommendations to the NRC on knowledge topics encompassing the safety related characteristics of emerging medical technologies required for Authorized Users to fulfill their radiation safety-related duties and supervision roles; the methods on how knowledge topics should be acquired; and consideration for continuing education, vendor training for new medical uses, and training on the NRC regulatory requirements.	Dr. Michael Folkert, Chair Dr. Richard Harvey Dr. Hossein Jadvar Mr. Zoubir Ouhib Ms. Megan Shober NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 2/25/16 Final Report Submitted 4/7/25 Final Report (Staff evaluation) Submitted 10/23/19 Draft Report (Staff evaluation) Submitted 10/6/19 Final Report (35.390) Submitted 2/27/19 Interim Report Submitted 2/19/18 Status Report (35.190) Submitted 4/26/17 Status Report Submitted 9/16/17
ACMUI Medical Events Subcommittee	To review Medical Events (MEs) to advise the Advisory Committee on the Medical Use of Isotopes (ACMUI) and United States Nuclear Regulatory Commission (NRC) about emerging trends that may need regulatory attention.	Dr. Richard Harvey, Chair Dr. Michael Folkert Mr. Richard Green Dr. Joanna Fair Mr. Zoubir Ouhib Dr. Harvey Wolkov Consultant: Dr. Fritz Angle NRC Staff Resource: Mr. Daniel DiMarco	Subcommittee established 3/19/15 ACMUI Medical Event Presentations can be found on NRC medical toolkit.

Past Subcommittee

Subcommittee Name	Subcommittee Charge	Subcommittee Members	Status
Financial Assurance Requirements for Disposition of Category 1 – 3 Byproduct Material Radioactive Sealed Sources Subcommittee	To review and comment on the NRC staff’s regulatory basis document. * On April 8, 2024, the ACMUI Chair created a subcommittee to update the regulations in 10 CFR 30.35 that deal with financial assurance for Category 1 and Category 2 material. A joint NRC / Agreement State working group has drafted this document in accordance with Commission Direction.	Richard L. Green, BS Pharm (Chair) Rebecca Allen, MS Richard Harvey, DrPH Zoubir Ouhib, MS Harvey B. Wolkov, MD NRC Staff Resource: Daniel Shaw	Subcommittee established 4/8/2024 Final Report Submitted on 9/10/2024 Draft Report Submitted on 8/8/2024 Subcommittee was deactivated on 9/10/24.
Bylaws Subcommittee (2024)	To provide recommendations to revise the AMCUI Bylaws in light of the Office of the Inspector General's (OIG) special inquiry with regards to the appearance of conflict of interest by members. The subcommittee should also ensure that any changes in the FACA rule are incorporated and sufficient information regarding conduct of meetings for ACMUI public meetings.	Ms. Rebecca Allen, Chair Mr. Richard Green Dr. Michael O’Hara Mr. Zoubir Ouhib Dr. Harvey Wolkov Staff Resource: Cindy Flannery	Subcommittee established 4/8/24 Final Report Submitted 11/4/24 Draft Report Submitted 10/4/24 Subcommittee deactivated 11/4/24
Training and Experience Requirements for All Modalities Subcommittee	To review and evaluate the training and experience requirements for all modalities in 10 CFR Part 35. *On February 2, 2024, the ACMUI Chair expanded the charge of the Training and Experience (T&E) for all modalities subcommittee to include a review of the staff’s draft training and experience implementation guidance. A joint NRC / Agreement State working group has drafted this guidance in accordance with Commission Direction.	*Membership Amended on February 2, 2024: Michael Folkert, MD PhD (chair) Richard Harvey, DrPH Hossein Jadvar, MD PhD Melissa C. Martin MS Megan L. Shober MS NRC Staff Resource: Cindy Flannery	Subcommittee established 2/24/2024 Final Report Submitted on July 3, 2024 Draft Report submitted on 05/22/2024
Akesis Galaxy RTi	To review and comment on the U.S. Nuclear Regulatory Commission (NRC) staff’s draft Akesis Galaxy® RTi Licensing Guidance.	Rebecca Allen Richard Harvey PhD Zoubir Ouhib, MS Megan Shober, MS Harvey Wolkov, MD (Chair) NRC Staff Resource: Daniel Shaw	Subcommittee was established on 12/08/23 Final Report submitted on 04/15/24 Draft Report Submitted on 03/06/24 Subcommittee was deactivated on 4/15/24.
Subcommittee on Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials Draft Proposed Rule	To review and comment on the draft proposed rule for the Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials rulemaking.	Ms. Rebecca Allen Dr. Richard Harvey Dr. Hossein Jadvar Mr. Josh Mailman Ms. Melissa Martin Ms. Megan Shober Staff Resource: Cindy Flannery	Subcommittee established 12/5/22 Final Report Submitted 5/17/23 Draft Report Submitted 3/16/24 Subcommittee deactivated 5/17/23
Subcommittee on Yttrium-90 Microsphere Brachytherapy Eye90 Microspheres Device	To review and comment on the NRC staff’s draft licensing guidance for the ABK Biomedical, Inc. Eye90 microspheres® manual brachytherapy device for hepatocellular carcinoma.	Dr. Michael Folkert Ms. Rebecca Allen Dr. Andrew Einstein Dr. Darlene Metter Mr. Zoubir Ouhib Consultant: Dr. John Angle Staff Resource: Sarah Spence	Subcommittee established 11/3/23 Final Report Submitted 4/24/24 Draft Report Submitted 3/16/24 Subcommittee deactivated 4/24/24
Y-90 Medical Event Subcommittee	To evaluate the issue of Y-90 microspheres medical events in more depth and, in consultation with vendors, propose methods to decrease the number of Y-90 microsphere-related medical events.	Dr. Vasken Dilsizian Dr. John F. Angle, Dr. Michael O’Hara (chair) Ms. Megan Shober Mr. Josh Mailman Ms. Melissa Martin Non-voting subcommittee consultant: Dr. John F. Angle NRC staff resource: Dr. Katie Tapp	Subcommittee established 10/04/21 Final Report Submitted 12/19/22 Draft Report Submitted 11/18/2022 Subcommittee was deactivated on 12/19/22.
Liberty Vision Subcommittee	To review the Liberty Vision technology and comment on the NRC staff’s draft Liberty Vision Y-90 Eye Brachytherapy Source Licensing Guidance.	Mr. Zoubir Ouhib (chair) Dr. Harvey Wolkov Ms. Megan Shober Dr. Michael O’Hara Ms. Rebecca Allen NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 10/04/21 Final Report submitted on April 24, 2024. Draft Report submitted on March 11, 2024. Subcommittee was deactivated on 4/24/24.
Emerging Medical Technologies/Rubidium-82 Generator Rulemaking Subcommittee	To review and comment on the staff’s regulatory basis for the Emerging Medical Technologies/Rubidium-82 Generator rulemaking.	Ms. Megan Shober (chair) Dr. Ronald Ennis Dr. Harvey Wolkov Dr. Richard Harvey Dr. Hossein Jadvar Non-voting subcommittee consultant: Dr. John F. Angle NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 08/18/22 Final Report Submitted 12/19/22 Draft Report Submitted 11/18/2022 Subcommittee was deactivated on 12/19/22.
Alpha Dart Subcommittee	To review the Alpha Dart technology and comment on the NRC staff’s draft Alpha Dart Licensing Guidance.	Dr. Ronald Ennis (chair) Dr. Hossein Jadvar Dr. Michael O’Hara Ms. Megan Shober Ms. Becky Allen Mr. Zoubir Ouhib NRC staff resource: Dr. Katie Tapp	Subcommittee established May 2021 Final Report Submitted 1/21/22 Draft Report Submitted 11/29/21 Subcommittee was deactivated on 1/21/22.
Subcommittee on Emerging Radiopharmaceutical Therapy Knowledge Requirements in Theranostics	To outline the knowledge and specific or specialized practice or policy requirements needed for the safe use and handling of emerging radiopharmaceuticals in theranostics.	Dr. Vasken Dilsizian Dr. Ronald Ennis Dr. Hossein Jadvar (Chair) Mr. Josh Mailman Dr. Michael O’Hara Mr Zoubir Ouhib NRC staff resource: Ms. Maryann Ayoade	Subcommittee established May 2021 Final Report Submitted 10/14/21 Draft Report Submitted 9/20/21 Subcommittee was deactivated on 4/24/24.
Medical Event Report for All Modalities Excluding Permanent Implant Brachytherapy	To propose appropriate criteria for Medical Event Reporting for events other than permanent implant brachytherapy	Dr. Vasken Dilsizian Dr. Ronald Ennis Mr. Zoubir Ouhib Dr. Chris Palestro Dr. John Suh (Chair) Dr. Pat Zanzonico NRC staff resource: Dr. Katie Tapp Membership Amended 10/6/16: Dr. Pat Zanzonico stepped down from the subcommittee. Mr. Frank Costello was appointed to the subcommittee.	Subcommittee established 10/9/15 Final Report Submitted 4/27/17 Subcommittee was deactivated on 4/27/17
Subcommittee on Extravasation	To review the U.S. Nuclear Regulatory Commission (NRC) staff’s Memorandum “Preliminary Evaluation of Radiopharmaceutical Extravasation and Medical Event Reporting” dated April 1, 2021 and provide feedback and recommendations.	Vasken Dilsizian Richard Green Melissa Martin (Chair) Michael Sheetz Megan Shober NRC staff resource: Ms. Lisa Dimmick	Subcommittee established on 04/03/19 Final Report Submitted 09/16/2021 Draft Report Submitted 07/30/2021 Subcommittee deactivated on 9/16/21 but reestablished on 3/7/24
Abnormal Occurrence Subcommittee	To define patient harm in abnormal occurrence (AO) To reassess the current AO criteria To define the goals of AO criteria reporting To determine if AO criteria is adequate for public health and safety	*Membership amended Chair (TBD) Dr. Ronald Ennis Dr. Hossein Jadvar Ms. Megan Shober Mr. Zoubir Ouhib NRC staff resource: Dr. Katie Tapp	Subcommittee established 03/30/20 Final Report Submitted 9/16/21 Draft Report Submitted 7/30/21 Subcommittee was deactivated on 9/16/21.
ACMUI COVID-19 Subcommittee	To review the impacts of COVID-19 on the medical community and provide recommendations for any regulatory relief measures in the areas of nuclear medicine and radiation oncology during the COVID-19 pandemic.	Dr. Vasken Dilsizian Mr. Richard Green Dr. Hossein Jadvar (chair) Ms. Melissa Martin Ms. Megan Shober Dr. Harvey Wolkov Non-voting subcommittee consultants: Mr. Gary Bloom and Mr. Zoubir Ouhib NRC staff resource: Ms. Lisa Dimmick	Subcommittee established 3/30/20 Final Report Submitted 5/4/20 Draft Report Submitted 4/27/20 Subcommittee was deactivated on 5/4/20.
Interventional Radiologist Subcommittee	To investigate the need for an interventional radiologist (IR) on the ACMUI, including whether an IR should be a non-voting consultant or full ACMUI member.	Dr. Vasken Dilsizian Dr. Ronald Ennis Dr. Hossein Jadvar Dr. Darlene Metter Ms. Megan Shober (chair) NRC staff resource: Dr. Katie Tapp	Subcommittee established 9/11/19 Final Report Submitted 4/6/20 Draft Report Submitted 2/25/20 Subcommittee was deactivated on 4/6/20.
Patient Intervention Subcommittee (re-established)	To evaluate the definition of patient intervention and other actions and circumstances that are exclusive of medical events.	Dr. Vasken Dilsizian Dr. Ronald Ennis Mr. Michael Sheetz (chair) Mr. Gary Bloom NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 9/11/19 Final Report Submitted 4/6/20 Draft Report Submitted 3/5/20 Subcommittee was deactivated as work continued in Appropriateness of medical event reporting subcommittee.
Patient Intervention Subcommittee (Re-established)	The new charge was to clarify Issue II (passive vs. active patient intervention) from the 10/8/15 ACMUI presentation on "Unintentional Treatment Outcome"	Mr. Frank Costello Dr. Vasken Dilsizian (chair) Dr. Ronald Ennis Dr. John Suh Ms. Laura Weil NRC staff resource: Ms. Maryann Ayoade	Subcommittee re-established 10/6/16 Draft Report Submitted 4/27/17 Final Report was incorporated as an addendum to the Medical Event Reporting and Impact on Medical Licensee Patient Safety Culture Final Report on 9/11/17. Subcommittee deactivated 9/11/17
Training and Experience Requirements for All Modalities Subcommittee	To review and evaluate the training and experience requirements for all modalities in 10 CFR Part 35. Charge Expanded 8/6/19: To review and comment on the staff's draft evaluation of training and experience requirements for radiopharmaceuticals requiring a written directive.*	*Membership Amended 9/10/2019: Dr. Ronald Ennis Dr. Darlene Metter Dr. A. Robert Schleipman (chair) Mr. Michael Sheetz Ms. Megan Shober NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 2/25/16 Draft Report (Staff evaluation) Submitted 10/6/19 Final Report (Staff evaluation) Submitted 10/23/19
Xcision® GammaPod™ Licensing Guidance Subcommittee	To review the draft Xcision® GammaPod™ Licensing Guidance	Mr. Zoubir Ouhib Mr. Mike Sheetz Ms. Megan Shober Dr. Harvey Wolkov (chair) NRC staff resource: Dr. Katie Tapp	Subcommittee established 5/16/19 Final Report Submitted 10/23/19 Subcommittee was deactivated on 10/23/19.
ACMUI Institutional Memory Subcommittee	To improve the ACMUI's institutional memory and provide possible recommendations for methods of tracking and/or retrieving ACMUI documents.	Dr. Ronald Ennis Dr. Michael O’Hara Dr. A. Robert Schleipman (chair) Ms. Megan Shober Ms. Laura Weil NRC staff resource: Ms. Kellee Jamerson	Subcommittee established 4/03/19 Final Report Submitted 10/23/19 Subcommittee was deactivated on 10/23/19.
Infiltrations and Medical Event Reporting Subcommittee	To review the NRC's 1980 determination related to infiltrations and medical event reporting [45 FR 31703].	Dr. Vasken Dilsizian Mr. Richard Green Ms. Melissa Martin (chair) Mr. Michael Sheetz Ms. Megan Shober Ms. Laura Weil NRC staff resource: Ms. Maryann Ayoade	Subcommittee established 4/03/19 Final Report Submitted 10/23/19 Subcommittee was deactivated on 10/23/19.
Yttrium-90 Microspheres Brachytherapy Sources and Devices TheraSphere® and SIR_Spheres ® Licensing Guidance, Rev. 10	To review the draft Revision 10 of the Yttrium-90 Microspheres Brachytherapy Sources and Devices TheraSphere® and SIR_Spheres ® Licensing Guidance	Dr. Vasken Dilsizian Ms. Melissa Martin Dr. Darlene Metter Dr. Michael O'Hara (chair) Mr. Zoubir Ouhib Dr. A. Robert Schleipman NRC staff resource: Dr. Katie Tapp	Subcommittee established 9/21/18 Draft Report Submitted 3/11/19 Final Report Submitted 5/9/19 Subcommittee was deactivated on 5/9/19.
Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material"	Review the revisions to Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material" *Note: Regulatory Guide 8.39 is being revised in two phases. Phase 1 updates the patient release guidance, including information for patient instructions and updates to Table 3. Phase 2 will include updates to the dosimetric equations, methodologies, and tables used to calculate dose to members of the public from released patients.	Dr. Vasken Dilsizian Ms. Melissa Martin Dr. A. Robert Schleipman Mr. Michael Sheetz (chair) Ms. Megan Shober Ms. Laura Weil NRC staff resource: Dr. Said Daibes	Subcommittee established 9/21/18 Phase 1 Draft Report Submitted 5/23/19 Phase 1 Final Report Submitted 6/19/19
ACMUI Bylaws (2019)	To review and update the ACMUI Bylaws, as needed, including a review of the role of the ACMUI Chair and his/her participation on subcommittees	Dr. A. Robert Schleipman Mr. Michael Sheetz Ms. Megan Shober Ms. Laura Weil (chair) NRC staff resource: Ms. Sophie Holiday	Subcommittee established 9/21/18 Draft Report Submitted 3/7/19 Final Report Submitted 4/10/19 Subcommittee was deactivated on 4/10/19.
Germanium-68/Gallium-68 Pharmacy Grade Generator Licensing Guidance, Revision 1	To review and provide comments on the the Draft Revision 1 to the Germanium-68/Gallium-68 Pharmacy Grade Generator Licensing Guidance	Ms. Melissa Martin Dr. Darlene Metter Mr. Michael Sheetz Ms. Megan Shober (chair) NRC staff resource: Dr. Said Daibes	Subcommittee established 9/21/18 Draft Report Submitted 11/30/2018 Final Report Submitted 5/06/19 Subcommittee was deactivated on 5/6/19.
Appropriateness of Medical Event Reporting Subcommittee	To review the appropriateness of the required elements of medical event reporting, the adherence to these requirements, and the recommended actions to improve reporting	Dr. Vasken Dilsizian Dr. Ronald Ennis (chair) Ms. Melissa Martin Mr. Zoubir Ouhib Ms. Megan Shober Ms. Laura Weil NRC staff resource: Ms. Lisa Dimmick	Subcommittee established 9/20/18 Final Report Submitted 10/23/19 Interim Report Submitted 3/25/19 Subcommittee was deactivated on 10/23/19
ACMUI Bylaws (2019)	*Charge Amended 9/11/19: To determine (1) Should there be term limits for the ACMUI Chair and Vice Chair? If so, how long? and (2) Should the ACMUI Vice Chair automatically become the ACMUI Chair?	Membership Amended 9/11/19: Mr. Michael Sheetz Ms. Megan Shober Dr. Harvey Wolkov (chair) NRC staff resource amended 9/11/19:* Ms. Kellee Jamerson	Subcommittee established 9/21/18 Final Report Submitted 4/6/20 Draft Report Submitted 3/2/20 Subcommittee was deactivated on 4/6/20.
Yttrium-90 Microspheres Brachytherapy Sources and Devices TheraSphere® and SIR_Spheres ® Licensing Guidance, Rev. 10	To review the draft Revision 10 of the Yttrium-90 Microspheres Brachytherapy Sources and Devices TheraSphere® and SIR_Spheres ® Licensing Guidance	Dr. Vasken Dilsizian Ms. Melissa Martin Dr. Darlene Metter Dr. Michael O'Hara (chair) Mr. Zoubir Ouhib Dr. A. Robert Schleipman NRC staff resource: Dr. Katie Tapp	Subcommittee established 9/21/18 Draft Report Submitted 3/11/19 Final Report Submitted 5/9/19 Subcommittee was deactivated on 5/9/19.
Appropriateness of Medical Event Reporting Subcommittee	To review the appropriateness of the required elements of medical event reporting, the adherence to these requirements, and the recommended actions to improve reporting	Dr. Vasken Dilsizian Dr. Ronald Ennis (chair) Ms. Melissa Martin Mr. Zoubir Ouhib Ms. Megan Shober Ms. Laura Weil NRC staff resource: Ms. Lisa Dimmick	Subcommittee established 9/20/18 Final Report Submitted 10/23/19 Interim Report Submitted 3/25/19 Subcommittee was deactivated on 3/25/19.
Physical Presence Requirements for the Leksell Gamma Knife® Icon ^™ Subcommittee	To propose the appropriate physical presence requirements for the Leksell Gamma Knife® Icon ^™ radiosurgery unit Charge Expanded 7/01/18: To review the draft revision of the Leksell Gamma Knife Perfexion and Leksell Gamma Knife Icon Licensing Guidance	Dr. Ronald Ennis Dr. John Suh (chair) Ms. Laura Weil Membership Amended 7/1/18 to add: Ms. Megan Shober and Mr. Zoubir Ouhib NRC staff resource: Ms. Sophie Holiday	Subcommittee established 4/26/17 Draft Report Submitted 8/31/18 (for comments on draft licensing guidance) Final Report Submitted 2/27/18 (for original charge) Subcommittee deactivated on 2/27/18.
Nursing Mother Guidelines Subcommittee	To review the radiation exposure from diagnostic and therapeutic radiopharmaceuticals including brachytherapy to the nursing mother and child	Dr. Vasken Dilsizian Dr. Darlene Metter (chair) Dr. Christopher Palestro Dr. Pat Zanzonico NRC staff resource: Dr. Said Daibes	Subcommittee established 4/26/17 Draft Report Submitted 2/01/18 Final Report Submitted 6/26/18 Final Report, Table Revised Submitted 1/31/19 Subcommittee was deactivated on 1/31/19.
Yttrium-90 Microsphere Brachytherapy Sources and Devices TheraSpheres and SIR-Spheres Licensing Guidance	To provide comments on the following: the removal of the AU manufacturer training Pathway 2 update the waste and disposal section on long-lived impurities; and addition of a section on autopsy and cremation of Y-90 microsphere patients	Mr. Frank Costello Dr. Sue Langhorst Dr. Darlene Metter (chair) Dr. Chris Palestro	Subcommittee established 7/25/16 Final Report Submitted on 10/07/16 Subcommittee was superseded by the Draft Rev. 10 Subcommittee established on 9/21/18
Medical Event Report and Impact on Safety Culture Subcommittee	The charge of the subcommittee is to: explore the impact of ME reporting and its impact on self-reporting (safety culture); identify potential ways to improve effectiveness of self-reporting in support of a culture of safety; and suggest ways to share ME reports and lessons-learned with the medical community to promote safety	Mr. Frank Costello Dr. Vasken Dilsizian Dr. Ronald Ennis Dr. Sue Langhorst (chair) Ms. Laura Weil Mr. Zoubir Ouhib will serve as a consultant to the subcommittee NRC staff resource: Dr. Katie Tapp	Subcommittee established 3/18/16 Final Report Submitted on 9/11/17 Subcommittee deactivated on 9/11/17.
Training and Experience for Alpha and Beta Emitters Subcommittee	To evaluate if the required 700 hours for training and experience for authorized users of alpha and beta emitters places hardship on the patient community. If so, the subcommittee should make recommendations for potential changes (rulemaking).	Dr. Vasken Dilsizian Dr. Ronald Ennis Dr. Sue Langhorst Dr. Chris Palestro (Chair) Ms. Laura Weil Dr. Pat Zanzonico	Subcommittee established 6/16/15 Final Report Submitted 3/16/16 Subcommittee deactivated 3/16/16
Subcommittee on Radioactive Seed Localization for Non-Palpable Breast Lesions	To review the existing 10 CFR 35.1000 licensing guidance for radioactive seed localization and make recommendations for revisions to the guidance	Dr. Philip Alderson Mr. Frank Costello Dr. Ronald Ennis (Chair) Dr. Darlene Metter Dr. Pat Zanzonico NRC staff resource: Ms. Sophie Holiday	Subcommittee established 3/19/15 Final Report Submitted 6/24/16 Subcommittee deactivated on 6/24/16.
Training and Experience for Alpha and Beta Emitters Subcommittee	To evaluate if the required 700 hours for training and experience for authorized users of alpha and beta emitters places hardship on the patient community. If so, the subcommittee should make recommendations for potential changes (rulemaking).	Dr. Vasken Dilsizian Dr. Ronald Ennis Dr. Sue Langhorst Dr. Chris Palestro (Chair) Ms. Laura Weil Dr. Pat Zanzonico	Subcommittee established 6/16/15 Final Report Submitted 3/16/16 Subcommittee deactivated 3/16/16
Patient Intervention Subcommittee	To review and evaluate the phrase "patient intervention"	Dr. Alderson Mr. Frank Costello Dr. Vasken Dilsizian (Chair) Dr. Ronald Ennis Dr. John Suh Ms. Laura Weil NRC staff resource: Dr. Sandy Gabriel	Subcommittee established 3/19/15 No formal report provided. Patient Intervention Subcommittee Subcommittee was re-established on 10/6/16.
Advanced Notice for Proposed Rulemaking for 10 CFR Part 20 Subcommittee	To review the advanced notice of proposed rulemaking for Title 10 Code of Federal Regulations Part 20, "Standards for Protection Against Radiation"	Mr. Frank Costello Dr. Vasken Dilsizian Dr. Sue Langhorst (chair) Mr. Mattmuller Dr. Pat Zanzonico	Subcommittee established 9/30/14 Final Report Submitted 1/29/15 Subcommittee deactivated 1/29/15
Medical Event Reporting Criteria of the Yttrium-90 Microspheres (35.1000) Guidance	To review the medical event reporting criteria of the yttrium-90 microspheres (35.100) guidance and recommend any changes.	Mr. Frank Costello Dr. Milton Guiberteau (chair) Dr. Sue Langhorst Dr. Chris Palestro Dr. Bruce Thomadsen Dr. James Welsh	Subcommittee established 5/8/14 Final Report Submitted 9/29/14 Subcommittee deactivated 9/29/14
Germanium-68 Decommissioning Funding Plan Subcommittee	To evaluate the cost of a decommissioning funding plan (DFP) for the use of Ge-68, its effect on the future clinical use of new Ga-68 radiopharmaceuticals and how appropriate regulatory relief may be gained. Charge amended 3/19/15: To estimate the number of potential Ge/Ga-68 generator licensees; and To make a recommendation to the Committee on which route of action it believes NRC should pursue to address the decommissioning funding plan issue.	Mr. Frank Costello Dr. Sue Langhorst Mr. Mattmuller (chair) Dr. Chris Palestro Dr. Pat Zanzonico.	Subcommittee established 5/8/14 Final Report Submitted 8/12/15 Subcommittee deactivated 7/29/16 when exemption memo was issued
Medical Policy Statement Subcommittee	To determine if the Policy Statement needed revision(s). In addition, the subcommittee was asked to address the following two questions: Stakeholders in the medical community have suggested that physicians are not performing permanent implant brachytherapy procedures because of NRC's current regulations in 10 CFR Part 35. Does the subcommittee believe this to be true; and Does the subcommittee believe the regulations in 10 CFR Part 35, as amended in the proposed rule, address this real or perceived issue?	Dr. Philip Alderson Dr. Milton Guiberteau Dr. Chris Palestro Dr. John Suh Dr. Bruce Thomadsen (chair)	Subcommittee established 1/30/14 Final Report Submitted 5/8/14 Subcommittee deactivated 12/5/14 when the Commission agreed not to update the Medical Policy Statement at this time

Page Last Reviewed/Updated Tuesday, July 08, 2025

Navigation

Spotlight

ACMUI Subcommittees

Active ACMUI Subcommittees

Past Subcommittee

Navigation

Spotlight

Choose a section

ACMUI Subcommittees

Active ACMUI Subcommittees

Past Subcommittee